Pathways to motor neuron degeneration in transgenic mouse models

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease marked by motor neuron loss.
• Abnormal neurofilament and peripherin protein aggregates are key pathological features in ALS.
• Mutations in superoxide dismutase 1 (SOD1) cause ~20% of familial ALS cases.

Purpose of the Study:

• Investigate the role of cytoskeletal abnormalities in motor neuron disease using transgenic mouse models.
• Elucidate the pathogenesis of ALS, particularly concerning SOD1 mutations and intermediate filament (IF) aggregation.

Main Methods:

• Utilized transgenic mouse models to study the effects of overexpressing different neurofilament proteins and mutant SOD1.
• Analyzed the impact of various intermediate filament aggregate types on motor neuron health and survival.
• Examined the complex pathways contributing to ALS pathogenesis, including non-neuronal cell involvement.

Main Results:

• Overexpression of wild-type neurofilament proteins (neurofilaments) generally resulted in well-tolerated perikaryal IF accumulations.
• Perikaryal swellings from NF-H overexpression demonstrated a protective effect against mutant SOD1 toxicity.
• Other IF aggregates, like those from peripherin or an NF-L mutant, appeared neurotoxic.
• Transgenic mice expressing mutant SOD1 showed complex results, indicating multiple disease pathways.

Conclusions:

• Different types of intermediate filament aggregates have disparate effects on motor neuron pathology in ALS models.
• Cytoskeletal abnormalities play a significant role in ALS pathogenesis, with varying toxicities.
• SOD1 toxicity is complex and likely involves multiple contributing factors, including non-neuronal cells.